One major pro-fibrotic pathway in cardiomyopathy among others is the induction of connective tissue growth factor (Ctgf) via Tgf-β1-mediated activation of extracellular signal-regulated kinases (ERK)1/2 (41–43). Here, TGFB1 is linked to cardiomyopathy.